[HTML][HTML] Comprehensive review of chromophobe renal cell carcinoma

R Garje, D Elhag, HA Yasin, L Acharya, D Vaena… - Critical reviews in …, 2021 - Elsevier
Chromophobe renal cell carcinoma (chRCC) is the third most common type of RCC with
distinct biology compared to other kidney cancer subtypes. The heterogeneity between the …

[HTML][HTML] Chromophobe renal cell carcinoma: current and controversial issues

H Moch, R Ohashi - Pathology, 2021 - Elsevier
It has been 35 years since Professor Thoenes and his colleagues discovered chromophobe
renal cell carcinoma (RCC). Since then, our knowledge about this tumour entity has …

[HTML][HTML] New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

K Trpkov, O Hes, SR Williamson, AJ Adeniran… - Modern Pathology, 2021 - Elsevier
Abstract The Genitourinary Pathology Society (GUPS) reviewed recent advances in renal
neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide …

Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival

S Dudani, G De Velasco, JC Wells, CL Gan… - JAMA network …, 2021 - jamanetwork.com
Importance There exists considerable biological and clinical variability between histologic
variants of metastatic renal cell carcinoma (mRCC). Data reporting on patterns of metastasis …

Systemic therapies for the management of non–clear cell renal cell carcinoma: what works, what doesn't, and what the future holds

P Zoumpourlis, G Genovese, NM Tannir… - Clinical genitourinary …, 2021 - Elsevier
Non–clear cell renal cell carcinoma (nccRCC) is a broad term that refers to a diverse group
of tumors, each with its own distinct biologic and therapeutic profile. The management of …

Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme

R Ohashi, G Martignoni, A Hartmann, A Caliò… - Virchows Archiv, 2020 - Springer
A histological grading system of chromophobe renal cell carcinoma (chRCC) is highly
desirable to identify approximately 5–10% of tumors at risk for progression. Validation …

Renal cell carcinoma of variant histology: biology and therapies

P Msaouel, G Genovese… - Hematology/Oncology …, 2023 - hemonc.theclinics.com
Renal cell carcinomas (RCCs) are divided into distinct subtypes characterized by specific
molecular alterations. 1 Clear cell renal cell carcinoma (ccRCC) constitutes w75% a …

[HTML][HTML] Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates

R Alaghehbandan, CG Przybycin, V Verkarre… - Asian Journal of …, 2022 - Elsevier
Chromophobe renal cell carcinoma (ChRCC) is the third most common renal cell carcinoma
(RCC) subtype, which predominantly occurs in sporadic setting. ChRCCs are considered to …

Chromophobe renal cell carcinoma: results from a large single-institution series

J Casuscelli, MF Becerra, K Seier, BJ Manley… - Clinical genitourinary …, 2019 - Elsevier
Background The purpose of the study was to evaluate clinical features and prognostic
factors in a large single institutional cohort of chromophobe renal cell carcinoma (ChRCC) …

Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: a histomorphology‐based cross‐organ study

R Morisue, M Kojima, T Suzuki… - … Journal of Cancer, 2023 - Wiley Online Library
Sarcomatoid carcinoma (SC), which can occur in any organ, is a rare disease. To elucidate
common characteristics of SC beyond organs, we evaluated clinicopathological and …